HK2 and neoplasm: More and more evidence further supports the use of natural compounds such as paeonol [92], the active ingredient DT-13 of ophiopogon [93], and targeted inhibitors to enhance chemotherapy sensitivity and reduce tumor invasion of GC by disrupting HK2 and related pathways.